Biodefense Market

Biodefense Market Showing 6.9% CAGR Growth to 2024: Company Profiles & Growth Analysis

Posted on Updated on

This global Biodefense market report studies the industry based on one or more segments covering key players, types, applications, products, technology, end-users, and regions for historical data as well as provides forecasts for next few years.

Biodefense Market size forecast predicts over USD 17 billion in revenue by 2024; according to the latest research report.

Growing R&D spending for product innovation by key industry players and rising government research funding is expected to boost global biodefense market size. The presence of favorable federal government initiatives such as Project BioShield and Emergency Use Authorization of medical products is expected to catapult growth in the coming years. Moreover, growing threats regarding chemical, biological, and radiological warfare should heighten the need for continuous technology upgrades. The biodefense market has witnessed surge in R&D investments aimed at catering to threats involving the recent Ebola outbreak.

The emergence of technologically advanced centers for innovation in advanced development and manufacturing, continuous development of next generation detection systems such as CIP based detection, environmental detection and vulnerability detection is anticipated to drive revenue.

Global surveillance measures against the threats of bioterrorism and pandemic outbreaks has improved public health preparedness to effectively monitor and control community health. The focus is shifted towards development of precise analytical instruments, tests and procedures that detects and identifies bio threat agents. Countries have entered into mass production and stockpiling of antibiotics effective against the bacterial agents and resumed the halted offensive biological weapons programs

Protective measures implemented by international associations will serve as strategic deterrents. For instance, a treaty between U.S. and North Atlantic Treaty Organization (NATO) reinstates the commitment of the use of weapons of mass destruction against any member state would represent an attack against all NATO members. Other protective and instant response measures include development of the CDC Rapid Response and Advanced Technology laboratory, National Electronic Data Surveillance System (NEDSS), Health Alert Network (HAN), and Epidemic Information Exchange (Epi-X). These protective measures are anticipated to reduce the cost of responding to any emergency bio threat.

Request a sample of this premium report at:

North America biodefense market share represented the largest regional segment in 2015. Implementation of Project BioShield coupled with presence of government and private funding are some of the factors fueling demand. Furthermore, countries such as Japan and China should experience high growth in the coming years due to advancing healthcare infrastructure, and the presence of favorable political and regulatory environment.

Key insights from the report include:

Global biodefense market size was driven by the anthrax segment, which was USD 3 billion in 2015 and is anticipated to grow at 5% from 2016 to 2024.

Revenue growth will be propelled by smallpox segment that is set to increase at 7.4% CAGR estimations to exceed USD 4 billion by 2024.

Eminent companies entered into contracts with the government for addressing a range of healthcare, scientific, national security and international security issues, which has led to high U.S. biodefense market share.

European countries of Germany and UK are set to witness lucrative growth rate due to designated funding policies in place.

Companies operating in the industry include Xoma Corporation, Emergent Biosolutions, Cleveland BioLabs, Nanotherapeutics, SIGA Technologies, etc. Presence of extensive product portfolio and strong pipeline will contribute to profitability.

Request a discount on standard prices of this premium report at:

Selected points from Table of Contents of this report:

Chapter 1.    Methodology and Scope

1.1.    Research Methodology

1.1.1.    Initial data exploration

1.1.2.    Statistical model and forecast

1.1.3.    Industry insights and validation

1.2.        Data Sources

Chapter 2.    Executive Summary

2.1.    Biodefense industry 360 degree synopsis, 2012 – 2024

2.1.1.    Business trends

2.1.2.    Regional trends

2.1.3.    Product trends

Chapter 3.    Biodefense Industry Insights

3.1.    Industry segmentation

3.2.    Industry Size and forecast, 2012 – 2024

3.3.    Industry Impact forces

3.3.1.  Growth drivers Presence of favorable government initiatives Project BioShield Act, 2004 Emergency Use Authorization of Medical Products

3.3.2.    Industry pitfalls & challenges Low penetration in developing and underdeveloped countries

3.4.    Growth potential analysis

3.5.    Porter’s analysis

3.6.    PESTEL analysis

3.7     Market Insights, By type

3.7.1     Biological defense

3.7.2     Chemical defense product pipeline

3.7.3     Nuclear/ radiation defense product pipeline

For More Info:

About Us: allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:

Market Study Report

4 North Main Street,

Selbyville, Delaware 19975


Phone: 1-302-273-0910

US Toll Free: 1-866-764-2150


Web site: